PhotoniCare
NC - DurhamBiotechnology
Focus: PhotoniCare develops optical coherence tomography (OCT) technology for otolaryngological diagnostics, specifically targeting middle ear examination through its OtoSight platform. The company operates as an early-stage medical device biotech with a specialized focus on otitis media diagnosis.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About PhotoniCare
AI assessmentNot HiringNo open roles listed right now. Follow PhotoniCare to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
3 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
PhotoniCare OtoSight Middle Ear Scope
Otitis Media AcuteClinical Trials (1)
NCT04722770Clinical Development of Deep Learning for the OtoSight
N/AHelp build intelligence for PhotoniCare
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.